var data={"title":"Cyanocobalamin (vitamin B12): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Cyanocobalamin (vitamin B12): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5954?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=cyanocobalamin-vitamin-b12-patient-drug-information\" class=\"drug drug_patient\">see &quot;Cyanocobalamin (vitamin B12): Patient drug information&quot;</a> and <a href=\"topic.htm?path=cyanocobalamin-vitamin-b12-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Cyanocobalamin (vitamin B12): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155136\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>B-12 Compliance Injection;</li>\n      <li>Nascobal;</li>\n      <li>Physicians EZ Use B-12;</li>\n      <li>Vitamin Deficiency System-B12</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155180\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Vitamin, Water Soluble</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155139\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Aphthous ulcers, recurrent (off-label use):</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral (sublingual): 1,000 mcg once every evening for 6 months (Volkov 2009)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">IM: 1,000 mcg once daily for 7 days, followed by weekly for 1 month, followed by monthly for 6 months (Gulcan 2008)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Vitamin B<sub>12</sub> deficiency: Note</b>: Folic acid supplementation may also be required.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Intranasal (Nascobal): 500 mcg in 1 nostril once weekly</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral: 1,000 to 2,000 mcg daily for 1 to 2 weeks; maintenance: 1,000 mcg daily (Langan 2011; Oh 2003)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">IM, deep SubQ: May use initial treatment similar to that for pernicious anemia depending on severity of deficiency: 100 mcg daily for 6 to 7 days; if improvement, administer same dose on alternate days for 7 doses, then every 3 to 4 days for 2 to 3 weeks; once hematologic values have returned to normal, maintenance dosage: 100 mcg monthly.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Note:</b> Higher doses may be preferred, especially in cases of severe deficiency; consider alternate dosing regimens with initial doses ranging from 100 to 1,000 mcg every day or every other day for 1 to 2 weeks and maintenance doses of 100 to 1,000 mcg every 1 to 3 months (Oh 2003) <b>or </b>1,000 mcg once a week for 8 weeks followed by 1,000 mcg once a month (Langan 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Mild B<sub>12</sub> deficiency (eg, malabsorption, atrophic gastritis, metformin use, chronic acid reducing medication use):</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral: 500 to 1,000 mcg orally once daily (Stabler 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">IM: 1,000 mcg once daily or every other day for 1 week, then 1,000 mcg weekly for 4 to 8 weeks, and then 1,000 mcg monthly for life (Stabler 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Pernicious anemia:</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">IM: 1,000 mcg once daily or every other day for 1 week, then 1,000 mcg weekly for 4 to 8 weeks, then 1,000 mcg once monthly for life (Stabler 2013) <b>or</b> 100 to 1,000 mcg every day or every other day for 1 to 2 weeks followed by 100 to 1,000 mcg every 1 to 3 months (Oh 2003) <b>or </b>1,000 mcg once a week for 8 weeks followed by 1,000 mcg once a month for life (Langan 2011)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral: 1,000 to 2,000 mcg once daily for life (Stabler 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">IM, deep SubQ: Initial: 100 mcg once daily for 6 to 7 days; if improvement, administer same dose on alternate days for 7 doses, then every 3 to 4 days for 2 to 3 weeks; maintenance (once hematologic values have returned to normal): 100 mcg once monthly for life</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Severe B<sub>12</sub> deficiency (due to </b>\n      <b>gastrectomy, ileal resection, inflammatory bowel disease, sprue): </b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">IM: 1,000 mcg once daily or every other day for 1 week, then 1,000 mcg weekly for 4 to 8 weeks, then 1,000 mcg once monthly for life (Stabler 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral: 1,000 to 2,000 mcg once daily for life (Stabler 2013).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Vitamin B<sub>12</sub> repletion in gastric bypass surgery patients:</b> IM or SubQ: 1,000 mcg once daily until normal B<sub>12 </sub>levels are achieved and then resume supplementations dosage (ASBMS [Parrott 2017]) <b>or</b> 1,000 mcg IM once daily or every other day for 1 week, then 1,000 mcg IM weekly for 4 to 8 weeks, followed by supplementation dosing (Stabler 2013)<b>. </b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Vitamin B<sub>12</sub> supplementation <b>in gastric bypass surgery patients: </b></b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">IM or SubQ: 1,000 mcg once monthly (ASMBS [Parrott 2017]) <b>or</b> 1,000 mcg once monthly to 1,000 to 3,000 mcg once every 6 to 12 months (if oral or intranasal therapy are ineffective) (AACE/TOS/ACE [Mechanick 2013]) <b>or</b> 1,000 mcg IM once monthly for life (Stabler 2013).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral: 350 to 500 mcg (disintegrating tablet, sublingual, or liquid) once daily (ASMBS [Parrott 2017]) <b>or</b> &ge;1,000 mcg once daily (AACE/TOS/ACE [Mechanick 2013]) <b>or</b> 1,000 to 2,000 mcg orally once daily for life (Stabler 2013)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Intranasal: 500 mcg in one nostril once weekly (ASMBS [Parrott 2017]; AACE/TOS/ACE [Mechanick 2013]).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Vitamin B<sub>12</sub> supplementation to reduce toxicity associated with pemetrexed: </b>IM: 1,000 mcg every 9 weeks, beginning 1 to 3 weeks prior to pemetrexed treatment initiation; continue for 3 weeks after last pemetrexed dose; administer with oral folic acid supplementation (Scagliotti 2008; Vogelzang 2003); may administer cyanocobalamin on the same day as pemetrexed.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Vitamin B<sub>12</sub> supplementation to reduce toxicity associated with pralatrexate: </b>IM: 1,000 mcg every 8 to 10 weeks; administer with oral folic acid supplementation (O&rsquo;Connor 2011); begin cyanocobalamin within 10 weeks prior to pralatrexate treatment initiation. After the initial dose, may administer cyanocobalamin on the same day as pralatrexate.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155161\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=cyanocobalamin-vitamin-b12-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Cyanocobalamin (vitamin B12): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Vitamin B<sub>12</sub> deficiency: Note</b>: Folic acid supplementation may also be required.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Pernicious anemia: </b> Infants, Children, and Adolescents (based on limited data): IM, SubQ: Initial: 1,000 mcg/day for 2 to 7 days based upon clinical response; followed by 100 mcg once weekly for 4 weeks and then maintenance dose: 100 mcg/month; for severe anemia, a lower initial dose of 0.2 mcg/kg/dose for 2 days followed by the above regimen has been recommended; initial low dosage recommended due to potential hypokalemia observed during initial treatment of adults with severe anemia (Orkin 2015; Rasmussen 2001; Stabler 2013). For infants and young children, some experts have recommended doses as low as 50 to 100 mcg (Orkin 2015).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Severe B<sub>12</sub> deficiency:</b> Based on limited data; dosing regimens variable:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>Dietary deficiency: </i>Infants (breastfed with vitamin B<sub>12</sub> deficient mothers): IM: 250 to 1,000 mcg once daily for 1 to 2 weeks, followed by weekly dosing until patient recovers (Stabler 2013); patients with neurologic symptoms have been treated with doses of 1,000 mcg (Guez 2012; Roumeliotis 2012)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <i>Malabsorption: </i>Infants, Children, and Adolescents: IM: 250 to 1,000 mcg daily or every other day for 1 week, then weekly for 4 to 8 weeks, and then monthly for life; younger children should receive monthly doses of 100 mcg (Bjorke-Monsen 2011; Kliegman 2016; Stabler 2013). For infants and young children, some experts have recommended doses as low as 50 to 100 mcg (Orkin 2015).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155140\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15795913\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling. Some formulations may also contain aluminum, which may accumulate in renal impairment.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15795914\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155113\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, Injection: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">B-12 Compliance Injection: 1000 mcg/mL [contains benzyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Physicians EZ Use B-12: 1000 mcg/mL [contains benzyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Vitamin Deficiency System-B12: 1000 mcg/mL [contains benzyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1000 mcg/mL [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Liquid, Sublingual: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 3000 mcg/mL (52 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lozenge, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 50 mcg (100 ea); 100 mcg (100 ea); 250 mcg (100 ea, 250 ea); 500 mcg (100 ea, 250 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Injection: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1000 mcg/mL (1 mL, 10 mL, 30 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Nasal: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Nascobal: 500 mcg/0.1 mL (1 ea, 1.3 mL [DSC]) [contains benzalkonium chloride]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 100 mcg, 250 mcg, 500 mcg, 1000 mcg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 100 mcg, 500 mcg, 1000 mcg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Extended Release, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1000 mcg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Sublingual, Sublingual: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2500 mcg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Sublingual, Sublingual [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2500 mcg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155098\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155117\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">IM, SubQ: IM or deep SubQ are the preferred routes of administration. IV administration is not recommended.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Intranasal: Nasal spray (Nascobal): Administer 1 hour before or 1 hour after ingestion of hot foods/liquids.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Multi-dose bottle: Prior to initial dose, activate (prime) spray nozzle by pumping unit quickly and firmly until first appearance of spray, then prime twice more. The unit must be reprimed once immediately before each subsequent use. One bottle delivers 4 doses.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Unit dose spray device: Each device delivers 1 dose.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral: Not generally recommended due to variable absorption; however, oral therapy in appropriate doses has been effective for anemia if IM/SubQ routes refused or not tolerated. Some tablets are available for sublingual administration.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155116\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Vitamin B<sub>12</sub> deficiency:</b> Treatment of pernicious anemia, vitamin B<sub>12</sub> deficiency due to dietary deficiencies, gastrointestinal malabsorption, folic acid deficiency, parasitic infestation, inadequate secretion of intrinsic factor, and inadequate utilization of B<sub>12</sub> (eg, during neoplastic treatment); treatment of increased B<sub>12</sub> requirements due to pregnancy, thyrotoxicosis, hemorrhage, malignancy, liver or kidney disease</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50815312\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Aphthous ulcers (recurrent)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155105\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cardiovascular: Cardiac failure, peripheral vascular disease, thrombosis (peripheral)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Central nervous system: Abnormal gait, anxiety, ataxia, dizziness, headache, hypoesthesia, nervousness, pain, paresthesia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Pruritus, skin rash (transient), urticaria</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Diarrhea, dyspepsia, glossitis, nausea, sore throat, vomiting</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hematologic &amp; Oncologic: Polycythemia vera</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity: Anaphylaxis (parenteral)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Infection: Infection</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular &amp; skeletal: Arthritis, back pain, myalgia, weakness</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Respiratory: Dyspnea, pulmonary edema, rhinitis</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155120\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to cyanocobalamin (vitamin B<sub>12</sub>), cobalt, or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155102\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; CNS effects: Vitamin B<sub>12</sub> deficiency for &gt;3 months results in irreversible degenerative CNS lesions; neurologic manifestations will not be prevented with folic acid unless vitamin B<sub>12</sub> is also given. Spinal cord degeneration might also occur when folic acid used as a substitute for vitamin B<sub>12</sub> in anemia prevention.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypokalemia: According to the manufacturer, treatment of severe vitamin B<sub>12</sub> megaloblastic anemia may result in severe hypokalemia, sometimes fatal, due to intracellular potassium shift upon anemia resolution; however, in more recent experience, while some patients may experience hypokalemia with initial treatment, this is unlikely to be clinically significant (Carmel 2008).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Thrombocytosis: Treatment of severe vitamin B<sub>12</sub> megaloblastic anemia may result in thrombocytosis.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Leber disease: Patients with Leber disease who received B<sub>12</sub> treatment have suffered from severe rapid optic atrophy.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pernicious anemia: Appropriate use: IM/SubQ routes are used to treat pernicious anemia; oral and intranasal administration are not indicated until hematologic remission and no signs of nervous system involvement.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Polycythemia vera: Vitamin B<sub>12</sub> deficiency masks signs of polycythemia vera; vitamin B<sub>12</sub> administration may unmask this condition.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register, 2002). See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Intranasal administration: Efficacy in patients with nasal pathology or with other concomitant intranasal therapy has not been determined. Use with caution.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; IV administration: Avoid intravenous route; anaphylactic shock has occurred.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Test dose: Intradermal test dose of vitamin B<sub>12</sub> is recommended for any patient suspected of cyanocobalamin sensitivity prior to intranasal or injectable administration.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299104\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155106\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9302&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Chloramphenicol (Systemic): May diminish the therapeutic effect of Vitamin B12.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Colchicine: May decrease the serum concentration of Cyanocobalamin.<i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155133\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;display:inline\">Heavy ethanol consumption &gt;2 weeks may impair vitamin B<sub>12</sub> absorption.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F14207663\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. Water soluble vitamins cross the placenta. Absorption of vitamin B<sub>12</sub> may increase during pregnancy. Vitamin B<sub>12</sub> requirements may be increased in pregnant women compared to nonpregnant women. Serum concentrations of vitamin B<sub>12</sub> are higher in the neonate at birth than the mother (IOM, 1998).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3869860\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Vitamin B<sub>12</sub> is found in breast milk. Milk concentrations are similar to maternal serum concentrations and concentrations may be decreased in women who are vegetarians. Vitamin B<sub>12</sub> requirements may be increased in nursing women compared to non-nursing women (IOM 1998).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155123\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Strict vegetarian diets (eg, without eggs or dairy products) may result in vitamin B<sub>12</sub> deficiency.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Adequate intake (IOM 1998): </b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 6 months: 0.4 mcg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">7 to 12 months: 0.5 mcg daily</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Recommended intake (IOM 1998): </b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 3 years: 0.9 mcg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">4 to 8 years: 1.2 mcg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">9 to 13 years: 1.8 mcg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&ge;14 years: 2.4 mcg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pregnancy: 2.6 mcg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Lactation: 2.8 mcg daily</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155111\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Vitamin B<sub>12</sub>, hemoglobin, hematocrit, erythrocyte and reticulocyte count; folate and iron levels should be obtained prior to treatment; vitamin B<sub>12</sub> and peripheral blood counts should be monitored 1 month after beginning treatment, then every 3 to 6 months thereafter.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Evaluate serum methylmalonic acid and total homocysteine levels at baseline (prior to supplementation) in untreated patients to confirm vitamin B12 deficiency (and extent of deficiency); repeat to confirm adequate supplementation (Stabler 2013).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Megaloblastic/pernicious anemia: In addition to normal hematological parameters, serum potassium and platelet counts should be monitored during therapy. <b>Note:</b> Some patients may develop hypokalemia during initial treatment; however, this is unlikely to be clinically significant (Carmel 2008).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bariatric surgery: Vitamin B<sub>12</sub> levels at baseline and once a year postoperatively then every 3 to 6 months if supplemented; every trimester in pregnant females (Mechanick 2013). In patients on chronic administration of medications known to increase risk of B<sub>12</sub> deficiency (eg, colchicine, metformin, neomycin, nitrous oxide, proton pump inhibitors, seizure medication), screen every 3 months for the initial postoperative year and then annually (Parrott 2017). Serum methylmalonic acid (MMA) is the recommended assay to evaluate vitamin B<sub>12</sub> levels for patients who are asymptomatic, symptomatic, have a history of B<sub>12</sub> deficiency, or preexisting neuropathy (Parrott 2017). Monitor for early signs/symptoms of B<sub>12</sub> deficiency, including pernicious anemia (pale skin/eyes, glossitis, fatigue, anorexia, diarrhea) or neuropathy (numbness, paresthesia in extremities, ataxia, decreased reflexes), lightheadedness or vertigo, dyspnea, tinnitus, palpitations, and /or increased HR; monitor for advanced signs/symptoms of B<sub>12</sub> deficiency, including angina, HF symptoms and/or mental status changes (Parrott 2017).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155114\" class=\"block rer drugH1Div\"><span class=\"drugH1\">Reference Range</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Normal range of serum B<sub>12</sub> is 150 to 900 pg/mL; this represents 0.1% of total body content. Metabolic requirements are 2 to 5 mcg/day; years of deficiency are required before hematologic and neurologic signs and symptoms are seen. Occasional patients with significant neuropsychiatric abnormalities may have no hematologic abnormalities and normal serum cobalamin levels, 200 pg/mL (SI: &gt;150 pmol/L), or more commonly between 100 to 200 pg/mL (SI: 75 to 150 pmol/L).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastric bypass surgery patients: Normal B<sub>12</sub> range: 200 to 1,000 pg/mL; Deficiency critical range: B<sub>12</sub>: &lt;400 pg/mL (suboptimal) and &lt;200 pg/mL (deficient) (Parrott 2017).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155101\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Coenzyme for various metabolic functions, including fat and carbohydrate metabolism and protein synthesis, used in cell replication and hematopoiesis</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155119\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Megaloblastic anemia: IM: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Conversion of megaloblastic to normoblastic erythroid hyperplasia within bone marrow: 8 hours </p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Increased reticulocytes: 2 to 5 days </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Complicated vitamin B<sub>12</sub> deficiency: IM, SubQ: Resolution of: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Psychiatric sequelae: 24 hours </p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Thrombocytopenia: 10 days </p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Granulocytopenia: 2 weeks </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Oral: Variable from the terminal ileum; requires the presence of calcium and gastric &ldquo;intrinsic factor&rdquo; to transfer the compound across the intestinal mucosa </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Principally stored in the liver and bone marrow, also stored in the kidneys and adrenals </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Protein binding: Transcobalamins</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Converted in tissues to active coenzymes, methylcobalamin and deoxyadenosylcobalamin; undergoes some enterohepatic recycling </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Bioavailability: Intranasal solution: Intranasal gel: 8.9% (relative to IM formulation); Nascobal: 6.1% (relative to IM); Oral: Pernicious anemia: 1.2% </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Time to peak, serum: IM, SubQ: 30 minutes to 2 hours; Intranasal: 1.6 hours  </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (50% to 98%, unchanged drug)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155122\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Cyanocobalamin Injection)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1000 mcg/mL (10 mL): $51.02</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Nascobal Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mcg/0.1 mL (1): $158.04</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, controlled release</b> (Vitamin B-12 ER Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1000 mcg (60): $3.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Vitamin B-12 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">250 mcg (100): $3.47</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1000 mcg (100): $5.02</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F155124\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Ambe 12 (LU);</li>\n      <li>Ampavit (TH);</li>\n      <li>Arcored (ID);</li>\n      <li>B12 Ankermann (PL);</li>\n      <li>Bedoc (GR);</li>\n      <li>Bedodeka (IL);</li>\n      <li>Bedoze (PT);</li>\n      <li>Bedozil (BR);</li>\n      <li>Behepan (SE);</li>\n      <li>Betolvex (CH, DK, FI, SE);</li>\n      <li>Betolvex[inj.] (SE);</li>\n      <li>Cianocobalamina B12 Davi (PT);</li>\n      <li>Coba 1000 (LK);</li>\n      <li>Cobalin (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Cobamin Ophth Soln (HK);</li>\n      <li>Creliverol-12 (PE);</li>\n      <li>Cromatonbic B12 (ES);</li>\n      <li>Cytacon (LK);</li>\n      <li>Cytamen (AU, GB);</li>\n      <li>Dobetin (IT, VE);</li>\n      <li>Dodec (TR);</li>\n      <li>Ecovitamine B12 (FR);</li>\n      <li>Isopto B12 (ES);</li>\n      <li>Kiddi Pharmaton (MX);</li>\n      <li>Lagavit B12 (AE, BB, BH, BM, BS, BZ, CY, EG, GY, IQ, IR, JM, JO, KW, LB, LY, NL, OM, PR, QA, SA, SR, SY, TT, YE);</li>\n      <li>Ledoxina (MX);</li>\n      <li>Mono Vitamine B12 (FR);</li>\n      <li>Neurobene (CZ, HN);</li>\n      <li>Norivite-12 (ZA);</li>\n      <li>Optovite B12 (ES);</li>\n      <li>Parecon Forte (ZW);</li>\n      <li>Permadoze (PT);</li>\n      <li>Permadoze oral (PT);</li>\n      <li>Reedvit 10000 (AR);</li>\n      <li>Reticulogen (ES);</li>\n      <li>Rojamin (EC);</li>\n      <li>Rubramin (PH);</li>\n      <li>Sancoba (JP);</li>\n      <li>Tribedoce DX (MX);</li>\n      <li>Vegevit B12 (PL);</li>\n      <li>Vicapan N (DE);</li>\n      <li>Vitalen (MX);</li>\n      <li>Vitam-Doce (AR);</li>\n      <li>Vitamin B!1!2 (HR);</li>\n      <li>Vitamin B12 (HU);</li>\n      <li>Vitamin B12 Lannacher (AT);</li>\n      <li>Vitamin B12 Recip (SE);</li>\n      <li>Vitamina B12-Ecar (CO);</li>\n      <li>Vitamine B12-Dulcis (LU);</li>\n      <li>Vitaminum B12 (PL);</li>\n      <li>Vitarubin (CH)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR &sect;201.323.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Andres E, Noel E, and Goichot B, &ldquo;Metformin-Associated Vitamin B<sub>12</sub> Deficiency,&rdquo; <i>Arch Intern Med</i>, 2002, 162(19):2251-2.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/12390080/pubmed\" target=\"_blank\" id=\"12390080\">12390080</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"20508991\"></a>Bj&oslash;rke-Monsen AL and Ueland PM. Cobalamin status in children. <i>J Inherit Metab Dis</i>. 2011;34(1):111-119.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/20508991/pubmed\" target=\"_blank\" id=\"20508991\">20508991</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>. Last accessed: May 4, 2017.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"18606874\"></a>Carmel R. How I treat cobalamin (vitamin B12) deficiency. <i>Blood</i>. 2008;112(6):2214-2221. doi: 10.1182/blood-2008-03-040253.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/18606874/pubmed\" target=\"_blank\" id=\"18606874\">18606874</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cyanocobalamin injection [prescribing information]. Mendham, NJ: Somserset Therapeutics, LLC; May 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Goodman M, Chen XH, Daarwish D, &ldquo;Are U.S. Lower Normal B<sub>12</sub> Limits Too Low?,&rdquo; <i>J Am Geriatr Soc</i>, 1996, 44(10):1274-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/8856015/pubmed\" target=\"_blank\" id=\"8856015\">8856015</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"22726312\"></a>Guez S, Chiarelli G, Menni F, Salera S, Principi N, Esposito S. Severe vitamin B12 deficiency in an exclusively breastfed 5-month-old Italian infant born to a mother receiving multivitamin supplementation during pregnancy. <i>BMC Pediatr</i>. 2012;12:85.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/22726312/pubmed\" target=\"_blank\" id=\"22726312\">22726312</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"19011392\"></a>Gulcan E, Toker S, Hatipoglu H, et al. Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal. <i>Am J Med Sci.</i> 2008;336(5):379-382.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/19011392/pubmed\" target=\"_blank\" id=\"19011392\">19011392</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    IOM (Institute of Medicine), <i>Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B</i><sub>6</sub><i>, Folate, Vitamin B</i><sub>12</sub><i>, Pantothenic Acid, Biotin and Choline</i>, Washington, DC: National Academy Press, 1998.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kaushansky K, Kipps TJ. Hematopoietic Agents:Growth Factors, Minerals, and Vitamins. <i>Goodman &amp; Gilman's: The Pharmacological Basis of Therapeutics, 12e</i> New York, NY: McGraw-Hill; . http://accessmedicine.mhmedical.com/content.aspx?bookid=1613&amp;sectionid=102161502. Accessed November 27, 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kliegman RM, Stanton BMD, St. Geme J, Schor NF, eds. <i>Nelson' s Textbook of Pediatrics</i>. 20th ed. Philadelphia, PA: Saunders Elsevier; 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. <i>JAMA</i>. 2013;310(22):2435-2442.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/24327038/pubmed\" target=\"_blank\" id=\"24327038\">24327038</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lane LA and Rojas-Fernandez C, &ldquo;Treatment of Vitamin B<sub>12</sub>-Deficiency Anemia: Oral versus Parenteral Therapy,&rdquo; <i>Ann Pharmacother</i>, 2002, 36(7-8):1268-72.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/12086562/pubmed\" target=\"_blank\" id=\"12086562\">12086562</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Langan RC and Zawistoski KJ, &ldquo;Update on Vitamin B12 Deficiency,&rdquo; <i>Am Fam Physician</i>, 2011, 83(12):1425-30.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/21671542/pubmed\" target=\"_blank\" id=\"21671542\">21671542</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lindenbaum J, Healton EB, Savage DG, et al, &ldquo;Neuropsychiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytosis,&rdquo; <i>N Engl J Med</i>, 1988, 318(26):1720-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/3374544/pubmed\" target=\"_blank\" id=\"3374544\">3374544</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"23537696\"></a>Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic &amp; Bariatric Surgery. <i>Surg Obes Relat Dis</i>. 2013;9(2):159-191.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/23537696/pubmed\" target=\"_blank\" id=\"23537696\">23537696</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Nascobal (cyanocobalamin) [prescribing information]. Spring Valley, NY: Par Pharmaceutical Companies; April 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Nelson Textbook of Pediatrics, 17th ed, Behrman RE, Kliegman RM, and Jenson HB, eds, Philadelphia, PA: WB Saunders Co, 2004.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"21245435\"></a>O'Connor OA, Pro B, Pinter-Brown L, et al. Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results from the Pivotal PROPEL Study. <i>J Clin Oncol</i>. 2011;29(9):1182-1189.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/21245435/pubmed\" target=\"_blank\" id=\"21245435\">21245435</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Oh R and Brown DL, &ldquo;Vitamin B<sub>12</sub> Deficiency,&rdquo; <i>Am Fam Physician</i>, 2003, 67(5):979-86.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/12643357/pubmed\" target=\"_blank\" id=\"12643357\">12643357</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Olszewski AJ, Szostak WB, Bialkowska M, et al, &ldquo;Reduction of Plasma Lipid and Homocysteine Levels by Pyridoxine, Folate, Cobalamin, Choline, Riboflavin, and Troxerutin in Atherosclerosis,&rdquo; <i>Atherosclerosis</i>, 1989, 75(1):1-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/2930611/pubmed\" target=\"_blank\" id=\"2930611\">2930611</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Orkin S, Nathan D, Ginsbirg, D, et al, eds. <i>Nathan and Oski's Hematology and Oncology of Infancy and Childhood</i>. 8th ed. Saunders; 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"28392254\"></a>Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. <i>Surg Obes Relat Dis</i>. 2017;13(5):727-741.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/28392254/pubmed\" target=\"_blank\" id=\"28392254\">28392254</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rasmussen SA, Fernhoff PM, and Scanlon KS, &ldquo;Vitamin B<sub>12</sub> Deficiency in Children and Adolescents,&rdquo; <i>J Pediatr</i>, 2001, 138(1):10-17.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/11148506/pubmed\" target=\"_blank\" id=\"11148506\">11148506</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Regland B, Gottfries CG, and Lindstedt G, &ldquo;Dementia Patients With Low Serum Cobalamin Concentration: Relationship to Atrophic Gastritis,&rdquo; <i>Aging (Milano)</i>, 1992, 4(1):35-41.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/1627675/pubmed\" target=\"_blank\" id=\"1627675\">1627675</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"22711730\"></a>Roumeliotis N, Dix D, Lipson A. Vitamin B(12) deficiency in infants secondary to maternal causes. <i>CMAJ</i>. 2012;184(14):1593-1598.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/22711730/pubmed\" target=\"_blank\" id=\"22711730\">22711730</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"18506025\"></a>Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. <i>J Clin Oncol</i>. 2008;26(21):3543-3551.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/18506025/pubmed\" target=\"_blank\" id=\"18506025\">18506025</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Schjonsby H, &ldquo;Vitamin B<sub>12</sub> Absorption and Malabsorption,&rdquo; <i>Gut</i>, 1989, 30(12):1986-91.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/2693230/pubmed\" target=\"_blank\" id=\"2693230\">2693230</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Schnyder G, Roffi M, Flammer Y, et al, &ldquo;Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention: The Swiss Heart Study: A Randomized Controlled Trial,&rdquo; <i>JAMA</i>, 2002, 288(8):973-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/12190367/pubmed\" target=\"_blank\" id=\"12190367\">12190367</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Silbergleit R and Lee DC, &ldquo;Bowel Obstruction and Radiopaque Vitamin B<sub>12</sub> &ldquo;Pseudobezoar&rdquo;,&rdquo; <i>Am J Emerg Med</i>, 1995, 13(1):112-3.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/7832937/pubmed\" target=\"_blank\" id=\"7832937\">7832937</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Smith AD, Refsum H. Vitamin B-12 and cognition in the elderly. <i>Am J Clin Nutr</i>. 2009;89(2):707S-711S.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/19116332/pubmed\" target=\"_blank\" id=\"19116332\">19116332</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"23301732\"></a>Stabler SP. Clinical practice. Vitamin B12 deficiency. <i>N Engl J Med</i>. 2013;368(2):149-160.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/23301732/pubmed\" target=\"_blank\" id=\"23301732\">23301732</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"12860938\"></a>Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. <i>J Clin Oncol</i>. 2003;21(14):2636-2644.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/12860938/pubmed\" target=\"_blank\" id=\"12860938\">12860938</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"19124628\"></a>Volkov I, Rudoy I, Freud T, et al. Effectiveness of vitamin B<sub>12</sub> in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial.<i> J Am Board Fam Med.</i> 2009;22(1):9-16.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/cyanocobalamin-vitamin-b12-drug-information/abstract-text/19124628/pubmed\" target=\"_blank\" id=\"19124628\">19124628</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9302 Version 186.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F155136\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F155180\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F155139\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F155161\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F155140\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F15795913\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F15795914\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F155113\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F155098\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F155117\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F155116\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F50815312\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F155105\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F155120\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F155102\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299104\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F155106\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F155133\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F14207663\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F3869860\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F155123\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F155111\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Reference Range\" href=\"#F155114\" class=\"outlineLink\">Reference Range</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F155101\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F155119\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F155122\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F155124\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9302|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=cyanocobalamin-vitamin-b12-patient-drug-information\" class=\"drug drug_patient\">Cyanocobalamin (vitamin B12): Patient drug information</a></li><li><a href=\"topic.htm?path=cyanocobalamin-vitamin-b12-pediatric-drug-information\" class=\"drug drug_pediatric\">Cyanocobalamin (vitamin B12): Pediatric drug information</a></li></ul></div></div>","javascript":null}